Intellectual Property

CPTech's 2003 reports for the RSA Competition Commission, in Hazel Tau et al.v GSK, Boehringer, et al

On August 13, 2014, the Republic of South Africa (RSA) Competition Commission (CC) released the redacted versions of the reports provided to the CC by CPTech in 2003 in the TAC competition case involving GSK and Boehringer Ingelheim. A complete set of the documents is available here, and links to individual documents are listed below.

PAIPO

Some key events in the early development of the proposal for a Pan African Intellectual Property Organization
Joelle Dountio
10 February 2013

US Congress

Hearings on intellectual property rights, 112th Congress

House of Representatives

USTR's 2012 Special 301 Report, focuses on largest developing country markets, and Canada

The 2012 USTR Special 301 Report was published on April 30, 2012. The report details USTR's unilateral standards for the granting and enforcement for a diverse set of intellectual property rights, and singles out countries that USTR claims do not meet those standards. The Report places the offending countries into different categories, including those on the “Priority Watch List,” the “Watch List” and those to have a “Special 306” review. According to USTR:

Damages for infringement

United States

USPTO award of $4 million in fy 2010 grants to groups advising developing countries on intellectual property issues

Last year the USPTO announced the award of $4 million in fy 2009 grants to advise developing couintries on intellectual property policies. The first set of grants were done under Arti Rai, then Administrator for External Affairs at USTPO. The grants went to a variety on pro-right owner groups, including those associated with Newt Gingrich and the Tea Party, and several supported by firms like Pfizer and Microsoft. Seven of the groups receiving the fy 2009 have in common the fact they received funding from either Microsoft or the Gates Foundation.

Wikileaks cables on the US opposition to Philippines legislation on affordable medicines

From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)

From September 19, 2005 to January 15, 2010, the US Department of State sent dozens of cables from Manila reporting on disputes in the Philippines regarding IPR and the pricing of pharmaceutical drugs. Much of the U.S. advocacy in the Philippines was done in close cooperation with Pfizer.

Implementing the Jordan FTA rules on exclusive rights in regulatory test data

September 2, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)

On August 30, 2011, Wikileaks published a December 19, 2005 cable written by Daniel Rubinstein. The cable illustrates the degree to which the U.S. Department of State monitors the implementation of the Jordan-US FTA agreement, as regards disputes over rules on data exclusivity.

Syndicate content